188 related articles for article (PubMed ID: 35806069)
1. The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
Thomas J; Torok MA; Agrawal K; Pfau T; Vu TT; Lyberger J; Chang H; Castillo AMM; Chen M; Remaily B; Kim K; Xie Z; Dillhoff ME; Kulp SK; Behbehani GK; Cruz-Monserrate Z; Ganesan LP; Owen DH; Phelps MA; Coss CC; Mace TA
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806069
[TBL] [Abstract][Full Text] [Related]
2. CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F; Torok M; Shakya R; Agrawal K; Deems A; Benner B; Hinton A; Shaffer J; Blaser BW; Noonan AM; Williams TM; Dillhoff M; Conwell DL; Hart PA; Cruz-Monserrate Z; Bai XF; Carson WE; Mace TA
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581043
[TBL] [Abstract][Full Text] [Related]
3. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs.
Liu H; Sun M; Liu Z; Kong C; Kong W; Ye J; Gong J; Huang DCS; Qian F
J Control Release; 2019 Feb; 296():40-53. PubMed ID: 30653981
[TBL] [Abstract][Full Text] [Related]
4. Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer.
Dou L; Liu H; Wang K; Liu J; Liu L; Ye J; Wang R; Deng H; Qian F
J Control Release; 2022 Sep; 349():876-889. PubMed ID: 35907592
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
[TBL] [Abstract][Full Text] [Related]
6. FcRn augments induction of tissue factor activity by IgG-containing immune complexes.
Cines DB; Zaitsev S; Rauova L; Rux AH; Stepanova V; Krishnaswamy S; Sarkar A; Kowalska MA; Zhao G; Mast AE; Blumberg LJ; McCrae KR; Poncz M; Hubbard JJ; Pyzik M; Blumberg RS
Blood; 2020 Jun; 135(23):2085-2093. PubMed ID: 32187355
[TBL] [Abstract][Full Text] [Related]
7. Neonatal Fc receptor expression in lymphoid and myeloid cells in systemic lupus erythematosus.
Yanis R; Bergua C; Christelle B; Maillot F; Bigot A; Beurier P; Ferreira-Maldent N; Diot E; Gouilleux-Gruart V
Lupus; 2021 Oct; 30(12):1938-1945. PubMed ID: 34634960
[TBL] [Abstract][Full Text] [Related]
8. FcRn mediates fast recycling of endocytosed albumin and IgG from early macropinosomes in primary macrophages.
Toh WH; Louber J; Mahmoud IS; Chia J; Bass GT; Dower SK; Verhagen AM; Gleeson PA
J Cell Sci; 2019 Oct; 133(5):. PubMed ID: 31444284
[TBL] [Abstract][Full Text] [Related]
9. The Neonatal Fc Receptor (FcRn): A Misnomer?
Pyzik M; Sand KMK; Hubbard JJ; Andersen JT; Sandlie I; Blumberg RS
Front Immunol; 2019; 10():1540. PubMed ID: 31354709
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Fc Receptor Regulation of Lung Immunoglobulin and CD103+ Dendritic Cells Confers Transient Susceptibility to Tuberculosis.
Vogelzang A; Lozza L; Reece ST; Perdomo C; Zedler U; Hahnke K; Oberbeck-Mueller D; Dorhoi A; Kaufmann SH
Infect Immun; 2016 Oct; 84(10):2914-21. PubMed ID: 27481246
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
12. Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody.
Kenniston JA; Taylor BM; Conley GP; Cosic J; Kopacz KJ; Lindberg AP; Comeau SR; Atkins K; Bullen J; TenHoor C; Adelman BA; Sexton DJ; Edwards TE; Nixon AE
J Biol Chem; 2017 Oct; 292(42):17449-17460. PubMed ID: 28878017
[TBL] [Abstract][Full Text] [Related]
13. Research progress on neonatal Fc receptor and its application.
Hu M; Wei S; Zhou W; Wang P
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):537-544. PubMed ID: 34704415
[TBL] [Abstract][Full Text] [Related]
14. Cross-species analysis of Fc engineered anti-Lewis-Y human IgG1 variants in human neonatal receptor transgenic mice reveal importance of S254 and Y436 in binding human neonatal Fc receptor.
Burvenich IJ; Farrugia W; Lee FT; Catimel B; Liu Z; Makris D; Cao D; O'Keefe GJ; Brechbiel MW; King D; Spirkoska V; Allan LC; Ramsland PA; Scott AM
MAbs; 2016; 8(4):775-86. PubMed ID: 27030023
[TBL] [Abstract][Full Text] [Related]
15. The immunologic functions of the neonatal Fc receptor for IgG.
Rath T; Kuo TT; Baker K; Qiao SW; Kobayashi K; Yoshida M; Roopenian D; Fiebiger E; Lencer WI; Blumberg RS
J Clin Immunol; 2013 Jan; 33 Suppl 1(Suppl 1):S9-17. PubMed ID: 22948741
[TBL] [Abstract][Full Text] [Related]
16. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
Pyzik M; Rath T; Kuo TT; Win S; Baker K; Hubbard JJ; Grenha R; Gandhi A; Krämer TD; Mezo AR; Taylor ZS; McDonnell K; Nienaber V; Andersen JT; Mizoguchi A; Blumberg L; Purohit S; Jones SD; Christianson G; Lencer WI; Sandlie I; Kaplowitz N; Roopenian DC; Blumberg RS
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2862-E2871. PubMed ID: 28330995
[TBL] [Abstract][Full Text] [Related]
17. Investigating the interaction between the neonatal Fc receptor and monoclonal antibody variants by hydrogen/deuterium exchange mass spectrometry.
Jensen PF; Larraillet V; Schlothauer T; Kettenberger H; Hilger M; Rand KD
Mol Cell Proteomics; 2015 Jan; 14(1):148-61. PubMed ID: 25378534
[TBL] [Abstract][Full Text] [Related]
18. FcRn expression in cancer: Mechanistic basis and therapeutic opportunities.
Rudnik-Jansen I; Howard KA
J Control Release; 2021 Sep; 337():248-257. PubMed ID: 34245786
[TBL] [Abstract][Full Text] [Related]
19. Neonatal Fc Receptor (FcRn) Enhances Tissue Distribution and Prevents Excretion of nab-Paclitaxel.
Li F; Yuan H; Zhang H; He M; Liao J; Chen N; Li Y; Zhou S; Palmisano M; Yu A; Pai M; Sun D
Mol Pharm; 2019 Jun; 16(6):2385-2393. PubMed ID: 31002261
[TBL] [Abstract][Full Text] [Related]
20. CCR4
Sharma V; Sachdeva N; Gupta V; Nada R; Jacob J; Sahni D; Aggarwal A
Immunobiology; 2022 May; 227(3):152210. PubMed ID: 35358941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
